Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives
Layna Mager,1,* Samantha Gardeen,2,* David R Carr,3 Kathryn T Shahwan3- 5 1College of Medicine, The Ohio State University, Columbus, OH, USA; 2Division of Dermatology, HealthPartners, Minneapolis, MN, USA; 3Department of Dermatology, The Ohio State University Medical Center, Columbus...
Saved in:
Main Authors: | Mager L (Author), Gardeen S (Author), Carr DR (Author), Shahwan KT (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma
by: Hanieh Zargham, MD, et al.
Published: (2022) -
Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma
by: Cesar A. Virgen, MD, PhD, et al.
Published: (2020) -
Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center
by: E. Ríos-Viñuela, et al.
Published: (2022) -
Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios
by: Komal Akhtar MD, et al.
Published: (2022) -
Intravascular squamous cell carcinoma treated with cemiplimab
by: Alexander N. Rose, BS, et al.
Published: (2021)